Sysmex is active in a broad spectrum of healthcare areas. In addtion
to information for healthcare professionals we also provide
applied information for privat individuals seeking assistance in our
areas of expertise.
At the moment we provide guidance and background info on
breast cancer. We welcome you to visit http://www.breast-cancer-diagnosis.co.uk/
A range of technologies to cover all bases
Sysmex diagnostic devices are known around the world for their reliability, accuracy and quality. Since we were founded over forty years ago, we have been driven by the desire to innovate so that we can do our job better. To improve the analysis capabilities of our devices so we can help clinicians help people more effectively.
In those forty years it is fair to say we have changed the haematological analysis landscape. Nowadays we are the global leader in the haematology market. This is to a large extent due to our focus on knowledge and technology – backed up by service and solution-based thinking.
Modern automated blood cell counters use various technologies to determine the parameters of a full blood count. When EDTA blood samples are aspirated by the analyser, blood is aliquoted (separated into small portions before being used in the various channels) and treated with various reagents to support the cell-specific properties. A defined volume is separated from these reagent blood mixtures and introduced into different measurement lines for detection. RBC and PLT are measured simultaneously in one detector using DC sheath flow detection . A cyanide-free reagent is used to transform the haemoglobin so that it can be measured by absorption photometry .
Our 5-part differential haematology analysers use fluorescence flow cytometry as the prime detection method for WBC, differential, reticulocytes and NRBC.